Quantitative Evaluation of the Immunodeficiency of a Mouse Strain by Tumor Engraftments
Wei Ye,Zhiwu Jiang,Guan-Xiong Li,Yiren Xiao,Simiao Lin,Yunxin Lai,Suna Wang,Baiheng Li,Bei Jia,Yin Li,Zhi-liang Huang,Jin Li,Fenglan Feng,Shuhua Li,Huihui Yao,Zixia Liu,Su Cao,Lin Xu,Yangqiu Li,Donghai Wu,Lingwen Zeng,Mei Zhong,Pentao Liu,Zhe-sheng Wen,Bing Xu,Yao,Duanqing Pei,Peng Li
DOI: https://doi.org/10.1186/s13045-015-0156-y
IF: 28.5
2015-01-01
Journal of Hematology & Oncology
Abstract:BACKGROUND:The mouse is an organism that is widely used as a mammalian model for studying human physiology or disease, and the development of immunodeficient mice has provided a valuable tool for basic and applied human disease research. Following the development of large-scale mouse knockout programs and genome-editing tools, it has become increasingly efficient to generate genetically modified mouse strains with immunodeficiency. However, due to the lack of a standardized system for evaluating the immuno-capacity that prevents tumor progression in mice, an objective choice of the appropriate immunodeficient mouse strains to be used for tumor engrafting experiments is difficult.METHODS:In this study, we developed a tumor engraftment index (TEI) to quantify the immunodeficiency response to hematologic malignant cells and solid tumor cells of six immunodeficient mouse strains and C57BL/6 wild-type mouse (WT).RESULTS:Mice with a more severely impaired immune system attained a higher TEI score. We then validated that the NOD-scid-IL2Rg-/- (NSI) mice, which had the highest TEI score, were more suitable for xenograft and allograft experiments using multiple functional assays.CONCLUSIONS:The TEI score was effectively able to reflect the immunodeficiency of a mouse strain.